{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":5,"n_cols":7,"rows_kept":5,"flags":["formulas_cached_only"]}
["Supplementary Table 4 Studies examining survival outcomes for HIV-infected cervical cancer"]
["Authour, year,(ref)","Year of sample collection","Country","FIGO stage","Treatment ","No. of HIV-infected patients","Survival outcomes reported"]
["Scott et al, 2016【10】","2010-2015","Botswana","IA-IVB","Concomitant chemoradiotherapy; Patients with poor performance status or stage IV received palliative radiation",231,"3-year survival, 35% (95%CI, 27%-44%)"]
["Hannah et al, 2018【7】","2007-2011","South Africa","IB1-IIIB","Concomitant chemoradiotherapy",71,"5-year survival, 35.9% (95%CI, 23.9%-48.0%)"]
["Surbhi, 2018【13】","2013-2015","Botswana","IA-IV","Chemoradiation therapy",96,"2-year survival, 65% (95%CI,54%-74%)"]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}